Lucid Diagnostics vs Picard Medical
Picard Medical reported revenue of $5 million in fiscal 2025, about the same as Lucid Diagnostics' $5 million in fiscal 2025. Lucid Diagnostics' revenue grew 8.3% in its latest year, and Picard Medical's grew 12.5%. Lucid Diagnostics had an operating margin of -1054.8%, against -268.4% at Picard Medical.
Side by side
| Lucid Diagnostics | Picard Medical | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $5M | $5M |
| Revenue growth | 8.3% | 12.5% |
| Revenue growth a year, last 5 years | — | — |
| Gross margin | −41.7% | −4.1% |
| Operating margin | −1,054.8% | −268.4% |
| Net margin | −1,232.7% | −546.6% |
| Free cash flow | −$47M | — |
| Free cash flow margin | −992.0% | — |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 101.8% | 356.1% |
| Last close | $0.39 | $6.30 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $245,000, sold $0 | — |
| Piotroski F-score | — | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Lucid DiagnosticsPicard Medical
Operating margin
Percent of revenue
Lucid DiagnosticsPicard Medical
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Lucid DiagnosticsPicard Medical
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Lucid Diagnostics and Picard Medical pages.